The Water Technology and Resilience Reauthorization Act extends the funding authorization for advanced drinking water technologies from 2027 through 2031. This change directly affects federal agencies responsible for implementing these programs by providing continued financial support for five additional years. The bill amends the Safe Drinking Water Act to ensure that resources remain available for developing and deploying new water treatment methods.
This bill extends the funding authorization for the Accelerating Access to Critical Therapies for ALS Act from 2026 to 2031, ensuring continued financial support for research into treatments for amyotrophic lateral sclerosis. It requires the Food and Drug Administration to review clinical trial data more rigorously by assessing patient enrollment numbers and requesting interim results from drug manufacturers before renewing research grants. Additionally, the legislation clarifies that clinical trials in phase 3 include combined phase 2/3 studies and planned trials that have not yet started enrolling participants. The bill also mandates the FDA to publish a report within a year of enactment detailing its progress on rare neurodegenerative disease action plans and how it coordinates with broader disease communities. Finally, it adjusts the timeline for a Government Accountability Office report to cover a five-year period instead of four.
This bill amends the Public Safety Officers' Benefit Program to improve processing of claims for officers injured or killed in the line of duty. It establishes clear timelines for the Bureau to notify claimants about missing information (90 days) and make determinations (270 days), with automatic interim benefits issued if deadlines aren't met. The bill requires regular outreach to public safety officers and underserved agencies, mandates annual audits of backlogged claims, and strengthens subpoena authority to obtain necessary information. It also creates a pathway for expedited processing when claims are approved by the 9/11 Victim Compensation Fund or World Trade Center Health Program. The bill does not change benefit amounts but aims to make the claims process more efficient and transparent for public safety officers and their families.
This bill (S 2677) amends U.S. trade law to expand how U.S. Customs and Border Protection (CBP) shares information about suspected intellectual property rights violations. It allows CBP to share nonpublic merchandise details - including data from online marketplaces, shipping companies, and freight forwarders - with these entities when CBP has a reasonable suspicion of violations. The bill also adds new provisions permitting CBP to share information with other parties deemed relevant by the Commissioner. It directly affects CBP, online platforms, shipping operators, and importers by changing information-sharing protocols for IP enforcement. The changes focus on clarifying and broadening the scope of permissible information sharing during trade inspections.
This bill amends the existing Northern Border Security Review Act to update reporting requirements for U.S. Customs and Border Protection. It mandates a threat analysis of northern border apprehensions (including sector-level data) by September 2, 2025, and every three years thereafter, and requires the DHS Secretary to update the border security strategy by September 2, 2026, and every five years, incorporating the latest analysis. The bill also adds a requirement for classified briefings to Congress within 30 days of each threat analysis submission. No new funding is authorized for these changes.
National Plan for Epilepsy Act This bill requires the Department of Health and Human Services (HHS) to establish a national plan, form an advisory council, and take other actions to address epilepsy. The requirements sunset on December 31, 2035. Specifically, the bill requires HHS to carry out a National Plan for Epilepsy to prevent, diagnose, treat, and cure epilepsy. In carrying out the plan, HHS must implement activities such as coordinating research and services across all federal agencies and soliciting public comments. Also, HHS must establish an Advisory Council on Epilepsy Research, Care, and Services. The advisory council must report to HHS and Congress every two years with an evaluation of federally funded efforts. Additionally, HHS must annually report to Congress with recommended actions based on its assessments of the nation’s progress on epilepsy.
This Senate resolution designates August 21, 2026, as Fentanyl Prevention and Awareness Day to honor victims of illicit fentanyl overdose and highlight the dangers of the synthetic opioid. The bill acknowledges that fentanyl is a potent drug often mixed with other substances or pressed into counterfeit pills, contributing significantly to recent overdose deaths in the United States. It encourages citizens, schools, and organizations to participate in educational activities and promote drug-free lifestyles on this specific date.
This Senate resolution designates September 2026 as National Child Awareness Month to highlight the work of charities and youth-serving organizations across the United States. The measure aims to increase public awareness of these groups, which provide essential services such as healthcare, education, and social support. It specifically recognizes the importance of addressing the needs of vulnerable children, including those experiencing homelessness, foster care, or trauma.
This Senate resolution designates the first week of August 2026 as "National Community Health Center Week" to recognize the role these facilities play in providing affordable primary care across the United States. The bill highlights that community health centers serve a diverse range of populations, including those in rural and urban areas, by offering integrated services such as mental health, dental, and pharmacy care. It encourages the general public to participate in the observance by visiting local centers and celebrating the partnership between these organizations and their communities.
The INSULIN Act of 2026 requires health insurance plans to limit insulin copayments to $35 per 30-day supply starting in 2027, with plans choosing to cap costs at 25% of the negotiated price after 2028. The bill also mandates that pharmacy benefit managers pass all rebates and discounts related to insulin directly to health plans rather than retaining them. Additional provisions include measures to speed up the approval process for generic and biosimilar insulin products, establish a pilot program to provide affordable insulin to uninsured individuals in 10 states, and create a resource center and hotline to help uninsured people access assistance programs.
This Senate resolution commemorates the 35th anniversary of Ukraine’s independence from the Soviet Union and recognizes the resilience of the Ukrainian people in pursuing sovereignty and democracy. The text affirms U.S. support for Ukraine’s territorial integrity, specifically rejecting the annexation of Crimea, while condemning Russia’s 2022 military invasion. It encourages the U.S. government to provide strong security guarantees to facilitate a lasting peace agreement and to integrate lessons from Ukraine’s defense innovations into American military readiness. Additionally, the resolution urges Ukraine to continue implementing reforms related to anti-corruption measures, free markets, and the rule of law.
This resolution designates the week of August 22 through August 30, 2026, as "National Park Week." It directly affects the public by encouraging responsible visits and support for the National Park System, which includes parks, battlefields, and historical sites located across the United States and its territories. The measure serves as a formal declaration to highlight the parks' role in recreation, education, and economic activity without altering any laws or funding.
